Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated ~~filer”,~~filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

As of ~~October 14, 2020,~~April 16, 2021, there were ~~8,829,732~~8,894,822 shares of the Registrant’s common stock outstanding.

	��	Three months ended					Nine months ended			Three months ended
		September 30,					September 30,			March 31,
		2020		2019			2020		2019	2021		2020

Net sales		$	37,434	$	56,568	$	148,407	$	187,836	$	37,038	$	58,494
Cost of products sold			41,861		51,260		145,988		166,052		37,286		53,585

Gross margin			(4,427)		5,308		2,419		21,784		(248)		4,909
Selling, general and administrative expenses			4,153		4,525		15,458		15,095		5,231		5,908

Operating (loss) income			(8,580)		783		(13,039)		6,689
Operating loss											(5,479)		(999)
Interest expense and other financing costs			642		1,045		2,401		2,980		550		952
Other income, net			(288)		(452)		(302)		(421)
Other expense (income), net											16		(17)

(Loss) income before income taxes			(8,934)		190		(15,138)		4,130
(Benefit) provision for income taxes			(1,934)		(577)		(3,396)		55
Loss before income taxes											(6,045)		(1,934)
Income taxes											(1,516)		(523)

Net (loss) income		$	(7,000)	$	767	$	(11,742)	$	4,075
Net loss										$	(4,529)	$	(1,411)

Net (loss) income per common share - Basic		$	(0.79)	$	0.09	$	(1.33)	$	0.46
Net loss per common share - Basic										$	(0.51)	$	(0.16)

Net (loss) income per common share - Diluted		$	(0.79)	$	0.09	$	(1.33)	$	0.46
Net loss per common share - Diluted										$	(0.51)	$	(0.16)

Weighted average shares of common stock outstanding
Basic			8,829,732		8,787,837		8,813,880		8,780,590		8,888,815		8,801,337
Diluted			8,829,732		8,879,441		8,813,880		8,870,240		8,888,815		8,801,337

The accompanying notes are an integral part of these consolidated financial statements.

	September 30,		December 31,		March 31,		December 31,
	2020		2019		2021		2020
	(Unaudited)				(Unaudited)
ASSETS
Current assets:
Cash	$	58	$	170	$	423	$	164
Accounts receivable (less allowance for doubtful accounts of $203 and $295, respectively)		26,451		35,595
Accounts receivable (less allowance for doubtful accounts of $203)						20,669		18,101
Inventory, net		120,947		147,402		111,596		111,380
Other current assets		4,824		8,300		7,177		7,471

Total current assets		152,280		191,467		139,865		137,116

Property, plant and equipment, net		168,623		176,061		163,693		164,983
Other long-term assets		997		871		1,079		947

Total assets	$	321,900	$	368,399	$	304,637	$	303,046

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	12,443	$	40,912	$	19,151	$	12,632
Accrued employment costs		3,235		4,449		3,087		1,826
Current portion of long-term debt		16,690		3,934		1,893		16,713
Other current liabilities		1,664		830		840		2,722

Total current liabilities		34,032		50,125		24,971		33,893

Long-term debt, net		43,879		60,411		49,672		33,471
Deferred income taxes		7,609		10,962		4,214		5,725
Other long-term liabilities, net		3,739		3,765		4,305		4,277

Total liabilities		89,259		125,263		83,162		77,366

Stockholders’ equity:
Senior preferred stock, par value $0.001 per share; 1,980,000 shares authorized; 0 shares issued and outstanding		-		-		-		-
Common stock, par value $0.001 per share; 20,000,000 shares authorized; 9,124,011 and 9,093,715 shares issued, respectively		9		9
Common stock, par value $0.001 per share; 20,000,000 shares authorized; 8,894,822 and 8,883,788 shares issued, respectively						9		9
Additional paid-in capital		96,197		94,982		94,585		94,276
Accumulated other comprehensive income (loss)		1		(31)
Accumulated other comprehensive loss						(30)		(45)
Retained earnings		138,745		150,487		126,911		131,440
Treasury stock, at cost; 294,279 common shares held		(2,311)		(2,311)

Total stockholders’ equity		232,641		243,136		221,475		225,680

Total liabilities and stockholders’ equity	$	321,900	$	368,399	$	304,637	$	303,046

The accompanying notes are an integral part of these consolidated financial statements.

		Nine months ended						Three months ended
		September 30,						March 31,
		2020			2019			2021			2020

Operating Activities:
Net (loss) income		$	(11,742	)	$	4,075
Net loss								$	(4,529	)	$	(1,411	)
Adjustments for non-cash items:	Adjustments for non-cash items:
Depreciation and amortization			14,721			14,235			4,834			5,025
Deferred income tax			(3,380	)		577			(1,518	)		(525	)
Share-based compensation expense			1,129			1,100			309			511
Changes in assets and liabilities:
Accounts receivable, net			9,144			(3,804	)		(2,568	)		(1,019	)
Inventory, net			25,093			(7,628	)		(639	)		12
Accounts payable			(25,399	)		(9,728	)		6,149			(9,161	)
Accrued employment costs			(1,214	)		(4,109	)		1,261			(687	)
Income taxes			207			(56	)		7			7
Other			4,045			(3,735	)		(1,689	)		(524	)

Net cash provided by (used in) operating activities			12,604			(9,073	)		1,617			(7,772	)

Investing Activity:
Capital expenditures			(8,480	)		(13,308	)		(2,683	)		(4,042	)

Net cash used in investing activity			(8,480	)		(13,308	)		(2,683	)		(4,042	)

Financing Activities:
Borrowings under revolving credit facility			101,559			145,688			29,541			49,232
Payments on revolving credit facility			(112,498	)		(123,097	)		(20,820	)		(34,872	)
Proceeds from Paycheck Protection Program Note			10,000			-
Proceeds from term loan facility									8,571			-
Payments on term loan facility, finance leases, and notes			(3,383	)		(3,424	)		(15,428	)		(2,483	)
Issuance of common stock under share-based plans			86			327
Net cash (used in) provided by financing activities			(4,236	)		19,494
Payments of financing costs									(539	)		-

Net decrease in cash and restricted cash			(112	)		(2,887	)
Cash and restricted cash at beginning of period			170			4,091
Net cash provided by financing activities									1,325			11,877

Cash and restricted cash at end of period		$	58		$	1,204
Net increase in cash									259			63
Cash at beginning of period									164			170

Cash at end of period								$	423		$	233

The accompanying notes are an integral part of these consolidated financial statements.

										Accumulated																			Accumulated
	Common				Additional					other										Common				Additional					other
	shares		Common		paid-in		Retained			comprehensive			Treasury			Treasury				shares		Common		paid-in		Retained			comprehensive			Treasury			Treasury
	outstanding		stock		capital		earnings			income (loss)			shares			stock				outstanding		stock		capital		earnings			loss			shares			stock

For the nine months ended September 30, 2020

For the three months ended March 31, 2021																			For the three months ended March 31, 2021

Balance at December 31, 2020																					8,883,788	$	9	$	94,276	$	131,440		$	(45	)		-	$		-
Share-based compensation																					11,034		-		309		-			-			-			-
Net gain on derivative instruments																					-		-		-		-			15			-			-
Net loss																					-		-		-		(4,529	)		-			-			-
Balance at March 31, 2021																					8,894,822	$	9	$	94,585	$	126,911		$	(30	)		-	$		-


For the three months ended March 31, 2020																			For the three months ended March 31, 2020

Balance at December 31, 2019		8,799,436	$	9	$	94,982	$	150,487		$	(31	)		294,279	$		(2,311	)			8,799,436	$	9	$	94,982	$	150,487		$	(31	)		294,279	$		(2,311	)
Share-based compensation		3,680		-		511		-			-			-			-				3,680		-		511		-			-			-			-
Net gain on derivative instruments		-		-		-		-			120			-			-				-		-		-		-			120			-			-
Net loss		-		-		-		(1,411	)		-			-			-				-		-		-		(1,411	)		-			-			-
Balance at March 31, 2020		8,803,116	$	9	$	95,493	$	149,076		$	89			294,279	$		(2,311	)			8,803,116	$	9	$	95,493	$	149,076		$	89			294,279	$		(2,311	)
Common stock issuance under
Employee Stock Purchase Plan		11,884		-		86		-			-			-			-
Share-based compensation		14,732		-		323		-			-			-			-
Net loss on derivative instruments		-		-		-		-			(25	)		-			-
Net loss		-		-		-		(3,331	)		-			-			-
Balance at June 30, 2020		8,829,732	$	9	$	95,902	$	145,745		$	64			294,279	$		(2,311	)
Share-based compensation		-		-		295		-			-			-			-
Net loss on derivative instruments		-		-		-		-			(63	)		-			-
Net loss		-		-		-		(7,000	)		-			-			-
Balance at September 30, 2020		8,829,732	$	9	$	96,197	$	138,745		$	1			294,279	$		(2,311	)

For the nine months ended September 30, 2019

Balance at December 31, 2018

8,752,490

$

9

$

93,100

$

146,191

$

1

292,855

$

(2,290
)
Common stock issuance under

Employee Stock Purchase Plan

9,270

-

128

-

-

-

-

Exercise of stock options

4,050

-

41

-

-

-

-

Share-based compensation

6,401

-

432

-

-

-

-

Net loss on derivative instruments

-

-

-

-

(67
)

-

-

Adoption of ASU 2018-02

-

-

-

21

(21
)

-

-

Net income

-

-

-

1,222

-

-

-

Balance at March 31, 2019

8,772,211

$

9

$

93,701

$

147,434

$

(87
)

292,855

$

(2,290
)
Common stock issuance under

Employee Stock Purchase Plan

11,182

-

152

-

-

-

-

Exercise of stock options

600

-

17

-

-

-

-

Share-based compensation

3,844

-

357

-

-

1,424

(21
)
Net gain on derivative instruments

-

-

-

-

154

-

-

Net income

-

-

-

2,086

-

-

-

Balance at June 30, 2019

8,787,837

$

9

$

94,227

$

149,520

$

67

294,279

$

(2,311
)
Common stock issuance under

Employee Stock Purchase Plan

-

-

(11
)

-

-

-

-

Share-based compensation

-

-

332

-

-

-

-

Net gain on derivative instruments

-

-

-

-

58

-

-

Net income

-

-

-

767

-

-

-

Balance at September 30, 2019

8,787,837

$

9

$

94,548

$

150,287

$

125

294,279

$

(2,311
)

The accompanying notes are an integral part of these consolidated financial statements.

Universal Stainless & Alloy Products, Inc., and its wholly-owned subsidiaries (collectively, “Universal,” “we,” “us,” “our,” or the “Company”), manufacture and market semi-finished and finished specialty steel products, including stainless steel, nickel alloys, tool steel and certain other alloyed steels. Our manufacturing process involves melting, remelting, heat treating, hot and cold rolling, forging, machining and cold drawing of semi-finished and finished specialty steels. Our products are sold to service centers, forgers, rerollers, original equipment manufacturers and wire redrawers. Our customers further process our products for use in a variety of industries, including the aerospace, power generation, oil and gas, heavy equipment, and general industrial manufacturing industries. We also perform conversion services on materials supplied by customers.

The accompanying unaudited consolidated statements include the accounts of Universal Stainless & Alloy Products, Inc. and its subsidiaries and are prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial reports and the instructions for Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared under U.S. GAAP have been condensed or omitted pursuant to such regulations. Although the December 31, ~~2019~~2020 consolidated balance sheet data was derived from the audited financial statements, it does not include all disclosures required by U.S. GAAP. However, we believe that the disclosures are adequate to make the information presented not misleading. These consolidated financial statements should be read in conjunction with our most recently audited financial statements and the notes thereto included in our Annual Report on Form 10-K as filed with the Securities and Exchange Commission. In the opinion of management, the accompanying financial statements include all adjustments necessary to present a fair presentation of the consolidated financial statements for the periods shown. Interim results are not necessarily indicative of the operating results for the full fiscal year or any future period. The preparation of these financial statements in conformity with U.S. GAAP requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and disclosure of contingent assets and liabilities. Actual results may differ from our estimates. The consolidated financial statements include our accounts and the accounts of our wholly–owned subsidiaries. We also consolidate, regardless of our ownership percentage, variable interest entities (each a “VIE”) for which we are deemed to have a controlling financial interest. All intercompany transactions and balances have been eliminated.

When we obtain an economic interest in an entity, we evaluate the entity to determine if the entity is a VIE, and if we are deemed to be a primary beneficiary. As a part of our evaluation, we are required to qualitatively assess if we are the primary beneficiary of the VIE based on whether we hold the power to direct those matters that most significantly impacted the activities of the VIE and the obligation to absorb losses or the right to receive the benefits of the VIE that could potentially be significant. Refer to Note 7, New Markets Tax Credit Financing Transaction, for a description of the VIEs included in our consolidated financial statements.

In ~~August 2018,~~December 2019, the Financial Accounting Standards Board ~~(“FASB”)~~ issued Accounting Standards Update (“ASU”) 2018-13, “Disclosure Framework–Changes to the Disclosure Requirements for Fair Value Measurement,” which modifies the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement, including the removal of certain disclosure requirements. The amendments in the ASU are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted upon issuance of the ASU. An entity is permitted to early adopt any removed or modified disclosures upon issuance of the ASU and delay adoption of the additional disclosures until the effective date. We adopted this guidance as of January 1, 2020 and the adoption did not have a material impact on our consolidated financial statements.

~~In December 2019, the FASB issued ASU~~ 2019-12, “Income Taxes - Simplifying the Accounting for Income Taxes (Topic 740),” which simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments in this ASU also improve consistency and simplify other areas of Topic 740 by clarifying and amending existing guidance. The amendments in this ASU will be applied using different approaches depending on what the specific amendment relates to and, for public entities, are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. An entity is permitted to early adopt the guidance, and we early adopted ASU 2019-12 as of January 1, 2020. The adoption did not have a material impact on our consolidated financial statements.

The Company considers the applicability and impact of all ASUs. Recently issued ASUs not listed ~~here~~ were assessed and were determined ~~to be either~~ not applicable, or are expected to have minimal impact on our consolidated financial statements.

The following table sets forth the computation of basic and diluted net income per common share:

	Three months ended					Nine months ended					Three months ended
	September 30,					September 30,					March 31,
(dollars in thousands, except per share amounts)	2020			2019		2020			2019		2021			2020

Numerator:
Net (loss) income	$	(7,000	)	$	767	$	(11,742	)	$	4,075
Net loss											$	(4,529	)	$	(1,411	)

Denominator:
Weighted average number of shares of common stock outstanding		8,829,732			8,787,837		8,813,880			8,780,590		8,888,815			8,801,337
Weighted average effect of dilutive share-based compensation		-			91,604		-			89,650		-			-
Diluted weighted average number of shares of common stock outstanding		8,829,732			8,879,441		8,813,880			8,870,240		8,888,815			8,801,337

Net (loss) income per common share:
Net (loss) income per common share - Basic	$	(0.79	)	$	0.09	$	(1.33	)	$	0.46
Net (loss) income per common share - Diluted	$	(0.79	)	$	0.09	$	(1.33	)	$	0.46
Net loss per common share:
Net loss per common share - Basic											$	(0.51	)	$	(0.16	)
Net loss per common share - Basic											$	(0.51	)	$	(0.16	)

We had options to purchase ~~821,025~~757,775 and ~~609,750~~741,550 shares of common stock outstanding at a weighted average price of ~~$21.71~~$21.78 and ~~$26.71~~$24.27 for the three months ended ~~September 30,~~March 31, 2021 and 2020, ~~and 2019,~~ respectively, which were excluded in the computation of diluted net (loss) income per common share. We had options to purchase 791,025 and 609,750 shares of common stock outstanding at a weighted average price of $22.23 and $26.71 for the nine months ended September 30, 2020 and 2019, respectively, which were excluded in the computation of diluted net (loss) incomeloss per common share. These options were not included in the computation of diluted net ~~(loss) income~~loss per common share because their exercise prices were greater than the average market price of our common stock. In addition, the calculation of diluted net ~~(loss)~~loss per share ~~excluded 510 shares and 4,803 shares,~~ for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2021 and 2020, respectively, excluded 30,553 and 19,650 shares for the assumed exercise of stock options as a result of being in a net loss position.

The Company’s revenues are primarily comprised of sales of products. Revenue is recognized when the Company satisfies its performance obligation under the contract by transferring the promised product to its customer that obtains control of the product. A performance obligation is a promise in a contract to transfer a distinct product to a customer. Most of the Company’s contracts have a single performance obligation, as the promise to transfer products or services is not separately identifiable from other promises in the contract and, therefore, not distinct.

Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products. As such, revenue is recorded net of returns, allowances, customer discounts, and incentives. Sales and other taxes are excluded from revenues. Invoiced shipping and handling costs are included in revenue.

The Company’s revenue is primarily from products transferred to customers at a point in time. The Company recognizes revenue at the point in time in which the customer obtains control of the product, which is generally when product title passes to the customer upon shipment.

We have determined that there are certain customer agreements involving production of specified product grades and shapes that require revenue to be recognized over time, in advance of shipment, due to there being no alternative use for these grades and shapes without significant economic loss. Also, the Company maintains an enforceable right to payment including a normal profit margin from the customer in the event of contract termination. Contract assets related to services performed and not yet billed of ~~$2.2~~$2.0 million and $2.3 million are included in Accounts Receivable in the Consolidated Balance Sheets at ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019.~~2020, respectively.

The Company has elected the following practical expedients allowed under Accounting Standards Codification Topic 606:


	Three months ended September 30,				Nine months ended September 30,					Three months ended March 31,
	2020		2019			2020		2019		2021		2020
Net sales:
Specialty alloys	$	27,847	$	47,730	$		116,869	$	154,511	$	29,091	$	49,920
Premium alloys (A)		9,165		8,043			29,271		30,227		7,553		7,664
Conversion services and other sales		422		795			2,267		3,098		394		910

Total net sales	$	37,434		56,568	$		148,407		187,836	$	37,038		58,494

Our raw material and starting stock inventory is primarily ~~includes~~comprised of ferrous and non-ferrous scrap metal and alloys such as nickel, chrome, molybdenum, cobalt, vanadium and copper. Our semi-finished and finished steel products are work-in-process in various stages of production or are finished products waiting to be shipped to our customers.

Operating materials are primarily ~~include~~comprised of forge dies and production molds and rolls that are consumed over their useful lives. During the ~~nine~~three months ended ~~September 30,~~March 31, 2021 and 2020, ~~and 2019,~~ we amortized these operating materials in the amount of ~~$1.4~~$0.4 million and ~~$1.7~~$0.6 million, respectively. This expense is recorded as a component of cost of products sold on the consolidated statements of operations and included as a part of our total depreciation and amortization on the consolidated statements of cash flows.

Inventory is stated at the lower of cost or net realizable value with cost principally determined on a weighted average cost method. Such costs include the acquisition cost for raw materials and supplies, direct labor and applied manufacturing overhead. We assess market based upon actual and estimated transactions at or around the balance sheet date. Typically, we reserve for slow-moving inventory and inventory that is being evaluated under our quality control process. The reserves are based upon management’s expected method of disposition.

Due to ~~lower~~low activity levels at our production facilities caused by the COVID-19 pandemic, management revised its accounting estimates for the absorption of costs into ~~inventory.~~inventory during 2020. As a result, ~~$4.3~~$2.6 million of fixed overhead costs were not absorbed into inventory and ~~$2.1~~$1.8 million of negative operating efficiency variances were ~~incurred.~~incurred during the three months ended March 31, 2021. The total impact of ~~$6.4~~$4.4 million was charged directly to expense in the quarter.

	September 30,		December 31,		March 31,		December 31,
(in thousands)	2020		2019		2021		2020

Raw materials and starting stock	$	9,510	$	9,815	$	8,944	$	9,286
Semi-finished and finished steel products		103,606		127,713		95,423		94,928
Operating materials		12,210		13,090		11,198		11,502

Gross inventory		125,326		150,618		115,565		115,716
Inventory reserves		(4,379)		(3,216)		(3,969)		(4,336)

Total inventory, net	$	120,947	$	147,402	$	111,596	$	111,380

The Company periodically enters into leases in its normal course of business. At ~~September 30, 2020,~~March 31, 2021, the leases in effect were primarily related to mobile and other production equipment. The term of our leases is generally 60 months or less, and the leases do not have significant restrictions, covenants, or other nonstandard terms.

We adopted the guidance effective in Leases (Topic 842) on January 1, 2019. Adoption of this guidance did not change the balance sheet recognition of our finance leases or the income statement recognition of our finance or operating leases. As a result of adopting the guidance, the Company recorded lease liabilities and right-of-use assets related to its operating leases. The impact at adoption was immaterial to the Company’s consolidated financial statements.

Right-of-use assets and lease liabilities are recorded at the present value of minimum lease payments. For our operating leases, the assets are included in Other long-term assets on the consolidated balance sheets and are amortized within operating income over the respective lease terms. The long-term component of the lease liability is included in Other long-term liabilities, net, and the current component is included in Other current liabilities. For our finance leases, the assets are included in Property, plant and equipment, net on the consolidated balance sheets and are depreciated over the respective lease terms which range from three to five years. The long-term component of the lease liability is included in Long-term debt and the current component is included in Current portion of long-term debt.

The Company entered into 1 new lease agreement accounted for as an operating lease, and did not enter into any new lease agreements accounted for as a finance lease, during the ~~third~~first quarter of ~~2020.~~2021.

As of ~~September 30, 2020,~~March 31, 2021, future minimum lease payments applicable to operating and finance leases were as follows:

	Operating Leases		Finance Leases		Operating Leases		Finance Leases
2020	$	72	$	82
2021		269		319	$	238	$	255
2022		258		278		308		319
2023		165		242		214		240
2024		70		225		118		240
2025		3		112		6		80
Total minimum lease payments	$	837	$	1,258		884		1,134
Less amounts representing interest		(38)		(165)		(37)		(135)
Present value of minimum lease payments	$	799	$	1,093		847		999
Less current obligations		(270)		(261)		(312)		(286)
Total long-term lease obligations, net	$	529	$	832	$	535	$	713
Weighted-average remaining lease term		3.3 years		3.8 years		3.0 years		3.2 years

Right-of-use assets recorded to the consolidated balance sheet at ~~September 30, 2020~~March 31, 2021 were $0.8 million for operating leases and ~~$0.7~~$1.0 million for finance leases. For the three ~~and nine~~ months ended ~~September 30, 2020,~~March 31, 2021, the amortization of finance lease assets was $0.1 million, ~~and $0.3 million, respectively,~~ and was included in cost of products sold in the Consolidated Statements of Operations.

The Company ~~elected~~applies the practical expedient allowed under Leases (Topic 842) to exclude leases with a term of 12 months or less from the calculation of our lease liabilities and right-of-use assets.

In determining the lease liability and corresponding right-of-use asset for each lease, the Company calculated the present value of future lease payments using the interest rate implicit in the lease, when available, or the Company’s incremental borrowing rate. The incremental borrowing rate was determined with reference to the interest rate applicable under ~~our senior secured~~ revolving credit facility discussed in Note 6, Long-Term Debt, as this facility is collateralized by a first lien on substantially all of the assets of the Company and its term is similar to the term of our leases.

	September 30,		December 31,		March 31,		December 31,
(in thousands)	2020		2019		2021		2020

Revolving credit facility	$	28,541	$	39,480	$	27,200	$	18,479
Term loan						15,000		6,786
Paycheck Protection Program Note						10,000		10,000
Notes		15,000		17,000		-		15,000
Paycheck Protection Program Note		10,000		-
Term loan		7,143		8,215
Finance leases		1,093		1,026		999		1,070

Total debt		61,777		65,721		53,199		51,335
Less: current portion of long-term debt		(16,690)		(3,934)		(1,893)		(16,713)
Less: deferred financing costs		(1,208)		(1,376)		(1,634)		(1,151)

Long-term debt, net	$	43,879	$	60,411	$	49,672	$	33,471

On ~~August 3, 2018,~~March 17, 2021, we entered into the ~~First~~Second Amended and Restated Revolving Credit, Term Loan and Security Agreement ~~(“Credit~~(the “Credit Agreement”), with PNC Bank, National Association, as administrative agent and co-collateral agent (the “Agent”), Bank of America, N.A., as co-collateral agent (“Bank of America”), the Lenders (as defined in the New Credit Agreement) party thereto from time to time and PNC Capital Markets LLC, as sole lead arranger and sole ~~bookrunner.~~bookrunner (“PNC Capital Markets”). The Credit Agreement replaces our prior credit agreement, and provides for a senior secured revolving credit facility in an aggregate principal amount not to exceed ~~$110.0~~ $105.0 million (“Revolving Credit Facility”) and a senior secured term loan facility (“Term Loan”) in the amount of ~~$10.0~~$15.0 million (together with the Revolving Credit Facility, the “Facilities”)..

The Company was in compliance with all the applicable financial covenants on the date we entered into the Credit Agreement and at ~~all reporting periods through September 30, 2020.~~March 31, 2021.

The Facilities, which expire on ~~August 3, 2023~~March 17, 2026 (the ‘Expiration Date”), are collateralized by a first lien on substantially all of the assets of the company and its subsidiaries, except that no real property is collateral under the Facilities other than Company’s real property in North Jackson, Ohio.

Availability under the Credit Agreement is based on eligible accounts receivable and inventory. ~~Further, the~~The Company must maintain undrawn availability under the Credit Agreement of at least ~~an amount equal~~$11.0 million. That requirement can be overcome if the Company maintains a fixed charge coverage ratio of not less than 1.10 to ~~payments due~~1.0 measured on ~~the notes issued~~a rolling two-quarter basis and calculated in ~~connection~~accordance with the ~~acquisition~~terms of the ~~North Jackson facility, as defined in the~~ Credit Agreement ~~plus~~ ~~12.5~~.~~% of the maximum borrowing amount of $110.0 million “(Minimum~~

~~Liquidity”). At September 30, 2020, there were 0 payments due on the notes relevant to the Minimum Liquidity calculation. This requirement exists until the notes are paid in full, refinanced or~~ ~~extended.~~

The Company is required to pay a commitment fee of 0.25% based on the daily unused portion of the Revolving Credit Facility.

With respect to the Term Loan, the Company pays quarterly installments of the principal of approximately ~~$0.4~~$0.5 million, plus accrued and unpaid interest, on the first day of each fiscal quarter beginning after ~~September~~June 30, ~~2018.~~2021. To the extent not previously paid, the Term Loan will become due and payable in full on the Expiration Date.

Amounts outstanding under the Facilities, at the Company’s option, bear interest at either a base rate or a LIBOR based rate, in either case calculated in accordance with the terms of the Credit Agreement. Interest under the Credit Agreement is payable monthly. We elected to use the LIBOR based rate for the majority of the debt outstanding under the Facilities for the three months ended ~~September 30, 2020,~~March 31, 2021, which was ~~1.91%~~2.61% on our Revolving Credit Facility and ~~2.41%~~3.11% for the Term Loan.

~~The Credit Agreement contains customary affirmative and negative covenants. If a triggering event occurs as defined~~We incurred $0.5 million in additional financing costs in conjunction with the execution of the Credit Agreement, which were recorded to the ~~Company must maintain a fixed charge coverage ratio of not less than 1.10~~consolidated balance sheet at March 31, 2021 and will be amortized to ~~1.0 measured on a rolling four quarter basis and calculated in accordance with~~interest expense over the ~~terms~~life of the Credit Agreement.

At ~~September 30, 2020,~~March 31, 2021, we had total Credit Agreement related net deferred financing costs of approximately ~~$0.6~~$1.0 million. For the ~~nine~~three months ended ~~September 30, 2020,~~March 31, 2021, we amortized ~~approximately $0.2~~$0.1 million of those deferred financing costs.

On April 16, 2020, the Company entered into a promissory note, dated April 15, 2020, with PNC Bank, National Association, ~~(“PNC”),~~ evidencing an unsecured loan with a principal amount of $10.0 million made to the Company pursuant to the Paycheck Protection Program ~~(“PPP~~(the “PPP Term Note”) under the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The PPP Term Note is guaranteed by the United States Small Business Administration.

The PPP Term Note bears interest at a fixed annual rate of 1.00%, with the first six months of interest deferred. Beginning in November 2020, the Company will make 18 equal monthly payments of principal and interest with the final payment due in April 2022. The PPP Term Note may be accelerated upon the occurrence of an event of default.

The proceeds may be used to maintain payroll or make certain covered interest payments, lease payments and utility payments. Under the terms of the CARES Act, the Company may be granted forgiveness for all or a portion of loan granted under the PPP, with such forgiveness to be determined, subject to limitations, based on the use of the loan proceeds for payment of payroll costs and any payments of certain covered interest, lease and utility payments.

The PPP Term Note bears interest at a fixed annual rate of 1.00%, with the first six months of interest deferred. According to the terms of the PPP Term Note, the Company would begin to make 18 equal monthly payments of principal and interest in November 2020 with the final payment due in April 2022. The PPP Term Note may be accelerated upon the occurrence of an event of default. The Company applied for forgiveness of the PPP Term Note during the third quarter of 2020.

As of March 31, 2021, the Company has not made any principal or interest payments related to the PPP Term Note.

The Company anticipates forgiveness of the entire amount of the PPP Term Note; however, we are unable to estimate the timing of the completion of the forgiveness process. We have elected to classify the ~~entire~~full principal balance of the PPP Term Note within Long-term debt, net on the consolidated balance sheet as of ~~September 30, 2020.~~March 31, 2021. Under the existing terms of the PPP Term Note, if no forgiveness were granted ~~approximately $6.1 million of~~ the entire principal amount would be due within approximately twelve months.

In connection with the acquisition of the North Jackson facility, in August 2011, we issued $20.0 million in aggregate principal amount of notes to the sellers of the North Jackson facility as partial consideration of the acquisition.

On January 21, 2016, the Company entered into Amended and Restated Notes in the aggregate principal amount of $20.0 million (the “Notes”), each in favor of Gorbert Inc. (“Holder”). The Company’s obligations under the Notes ~~are~~were collateralized by a second lien on the same assets of the Company that collateralize the obligations of the Company under the Facilities. The Holder had the right to elect at any time on or prior to August 17, 2017 to convert all or any portion of the outstanding principal amount of the Notes. ~~The Holder’s conversion rights expired and are no longer subject to exercise.~~

The Notes were originally scheduled to mature on March 17, 2019. ~~On March 30, 2018,~~In 2019, the Company ~~provided notification of its intent to extend~~extended the maturity date to March 17, 2020 in accordance with the terms of the Notes. ~~Upon the Company’s extension of the maturity date of the Notes to March 17,~~In 2020, ~~principal payments in the aggregate of $2.0 million were made in March 2019. On March 18, 2019,~~ the Company ~~provided notification of its intent to extend~~extended the maturity date to March 17, 2021 in accordance with the terms of the Notes. ~~Upon~~The Company made partial principal payments on the ~~Company’s~~notes upon extension, and an aggregate principal amount of $15.0 million remained outstanding at the 2021 maturity ~~date of the Notes to~~date. On March 17, 2021, ~~principal payments in~~ the ~~aggregate of $2.0 million were made in March 2020.~~

~~There are no further extension options remaining, and~~Company paid the remaining ~~aggregate~~ principal balance ofand all applicable interest to settle the notes obligation.

The Notes ~~outstanding of $15.0 million has been classified within Current portion of long-term debt as of September 30, 2020.~~

~~In accordance with the terms of the Notes, the Notes have borne~~had an applicable interest at a rate of 6.0% per year ~~since~~from August 17, ~~2017.~~2017 until the time they were paid off. All accrued and unpaid interest iswas payable quarterly in arrears on ~~each~~ September 18, December 18, March 18 and June ~~18.~~18 of each year.

On March 9, 2018, the Company entered into a qualified New Markets Tax Credit (“NMTC”) financing program with PNC New Markets Investment Partners, LLC and Boston Community Capital, Inc. related to a new mid-size bar cell capital project at the Company’s Dunkirk, NY facility. PNC New Markets Investment Partners, LLC made a capital contribution and the Company made a loan to Dunkirk Investment Fund, LLC (“Investment

Fund”) under the qualified NMTC program. Through this financing transaction, the Company secured low interest financing and the potential for other future benefits related to its mid-size bar cell capital project.

In connection with the NMTC financing program, the Company loaned $6.7 million aggregate principal amount (“Leverage Loan”) due in March 2048, to the Investment Fund. Additionally, PNC New Markets Investment Partners, LLC contributed $3.5 million to the Investment Fund, and as

such, PNC New Markets Investment Partners, LLC is entitled to substantially all tax and other benefits derived from the NMTC. The Investment Fund then contributed the proceeds to a community development entity (“CDE”). The CDE then loaned the funds, on similar terms, as the Leverage Loan to Dunkirk Specialty Steel, LLC, a wholly-owned subsidiary of the Company. The CDE loan proceeds are restricted for use on the mid-size bar cell capital project.

The NMTC is subject to 100 percent recapture for a period of seven years as provided in the Internal Revenue Code. The Company is required to comply with various regulations and contractual provisions that apply to the NMTC arrangement. Non-compliance with applicable requirements could result in projected tax benefits not being realized and, therefore, require the Company to indemnify PNC New Markets Investment Partners, LLC for any loss or recapture of NMTCs related to the financing until the Company’s obligation to deliver tax benefits is relieved. The Company does not anticipate any credit recaptures will be required in connection with this arrangement.

As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the Company recorded $2.8 million within Other long-term liabilities related to this transaction, which represents the funds contributed to the Investment Fund by PNC New Markets Investment Partners, LLC.

This transaction also includes a put/call provision whereby the Company may be obligated or entitled to repurchase PNC New Markets Investment Partners, LLC’s interest in the Investment Fund. The Company believes that PNC New Markets Investment Partners, LLC will exercise the put option in March 2025, at the end of the recapture period, resulting in a gain of $2.8 million at that time. The value attributed to the put/call is negligible.

Direct costs incurred in structuring this financing transaction totaled $0.7 million. These costs were deferred and are amortized over the term of the loans.

The Company has determined that the Investment Fund and CDE are each a VIE, and that it is the primary beneficiary of each VIE. This conclusion was reached based on the following:

Because the Company is the primary beneficiary of each VIE, these entities have been included in the Company’s Consolidated Financial Statements.

The fair value hierarchy has three levels based on the inputs used to determine fair value, which are as follows:

Level 1 — Unadjusted quoted prices available in active markets for the identical assets or liabilities at the measurement date.

Level 2 — Unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability.

Level 3 — Unobservable inputs that cannot be corroborated by observable market data and reflect the use of significant management judgment. These values are generally determined using pricing models for which the assumptions utilize management’s estimates of market participant assumptions.

The fair value hierarchy requires the use of observable market data when available. In instances where the inputs used to measure fair value fall into different levels of the fair value hierarchy, the fair value measurement has been determined based on the lowest level input significant to the fair value measurement in its entirety. Our assessment of the significance of a particular item to the fair value measurement in its entirety requires judgment, including the consideration of inputs specific to the asset or liability.

The carrying amounts of our cash, accounts receivable and accounts payable approximated fair value at ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019~~2020 due to their short-term maturities (Level 1). The fair value of the Term Loan and Revolving Credit facility at ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019~~2020 approximated the carrying amount as the interest rate is based upon floating short-term interest rates (Level 2). The fair value of our Notes was approximately $15.0 million at ~~September 30, 2020 and $16.9 million at~~ December 31, ~~2019~~2020 (Level 2).

From time to time, various lawsuits and claims have been or may be asserted against us relating to the conduct of our business, including routine litigation relating to commercial and employment matters. The ultimate cost and outcome of any litigation or claim cannot be predicted with certainty. Management believes, based on information presently available, that the likelihood that the ultimate outcome of any such pending matter will have a material adverse effect on our financial condition, or liquidity or a material impact on our results of operations is remote, although the

resolution of one or more of these matters may have a material adverse effect on our results of operations for the period in which the resolution occurs.

Management estimates the annual effective income tax rate quarterly, based on current annual forecasted results. Items unrelated to current year ordinary income are recognized entirely in the period identified as a discrete item of tax. The quarterly income tax provision includes tax on ordinary income provided at the most recent estimated annual effective tax rate (“ETR”), increased or decreased for the tax effect of discrete items.

For the ~~nine~~three months ended ~~September 30,~~March 31, 2021 and 2020, ~~and 2019,~~ our estimated annual effective tax rates applied to ordinary income were ~~23.7%~~25.8% and ~~11.2%~~28.3%, respectively. The difference between the federal statutory rate of 21.0% and the projected annual ETR of ~~23.7%~~25.8% for ~~2020~~2021 is primarily due to research and development credits.

Discrete items during the ~~nine~~three months ended ~~September 30,~~March 31, 2021 and 2020 ~~and 2019~~ were not significant, and our ETR for the first quarter in each ~~period~~year was ~~22.4%~~25.1% and ~~1.3%~~27.0%, respectively.

The Company invoices certain customers in foreign currencies. In order to mitigate the risks associated with fluctuations in exchange rates with the USU.S. Dollar, the Company entered into foreign exchange forward contracts ~~during 2020 and 2019 for~~to mitigate the foreign currency risk related to a portion of these sales, and has designated these contracts as cash flow hedges.

~~At September 30, 2020, the~~ The notional value of contracts was ~~$1.4~~$0.9 million and $1.2 million at March 31, 2021 and December 31, 2020, respectively, and a related unrealized loss of less than $0.1 million was recorded in accumulated other comprehensive income at each date.

Additionally, the Company entered into a forward interest rate swap contract during 2020 to fix the interest rate on a portion of its variable-rate debt from January 1, 2021 to June 30, 2023. The forward interest rate swap was designated as a cash flow hedge. The notional amount of the contract at its inception and at March 31, 2021 was $16 million, and the ~~related accumulated unrealized gain included in other comprehensive loss was less than $0.1 million.~~

~~At December 31, 2019,~~notional amount will step down throughout the ~~notional value of contracts was $4.9 million, and the~~term. The contract had a related unrealized loss recorded in accumulated other comprehensive income ~~was~~of less than $0.1 ~~million.~~

~~There are many uncertainties regarding the currently ongoing coronavirus ("COVID-19") pandemic,~~million at March 31, 2021 and the Company continues to closely monitor the impact of the pandemic on all aspects of its business, including how it will continue to impact its customers, employees, suppliers, vendors, business partners and distribution channels. We are unable to predict the impact that COVID-19 will have on our future financial position and operating results due to numerous uncertainties. The Company expects to continue to assess the evolving impact of the COVID-19 pandemic and intends to make adjustments to its responses accordingly. December 31, 2020.

This Quarterly Report on Form 10-Q contains or incorporates forward looking statements within the meaning of the Private Securities Reform Act of 1995, which involves risks and uncertainties. The following information should be read in conjunction with the unaudited consolidated financial information and the notes thereto included in this Quarterly Report on Form 10-Q. You should not place undue reliance on these forward looking statements. Actual events or results may differ materially due to competitive factors and other factors referred to in Part 1A. Risk Factors in our Annual Report on Form 10-K for the year ended December 31, ~~2019,~~2020, our other filings with the Securities and Exchange Commission and elsewhere in this Quarterly Report. These factors may cause our actual results to differ materially from any forward looking statement. These forward looking statements are based on current expectations, estimates, forecasts, and projections about the industry and markets in which we operate, and management’s beliefs and assumptions. In addition, other written or oral statements that constitute forward looking statements may be made by us or on our behalf. Words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “could,” “estimate,” “may,” “target,” “project,” or variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict.

We manufacture and market semi-finished and finished specialty steel products, including stainless steel, nickel alloys, tool steel and certain other alloyed steels. Our manufacturing process involves melting, remelting, heat treating, hot and cold rolling, forging, machining and cold drawing of semi-finished and finished specialty steels. Our products are sold to service centers, forgers, rerollers, and original equipment manufacturers. Our customers further process our products for use in a variety of industries, including the aerospace, power generation, oil and gas, heavy equipment and general industrial markets. We also perform conversion services on materials supplied by customers.

Sales in the ~~third~~first quarter of ~~2020~~2021 were ~~$37.4~~$37.0 million, ~~a decrease~~an increase of ~~$15.0~~$5.7 million, or ~~28.7%~~18.2%, from the ~~second~~fourth quarter of 2020. During this period, sales to our largest end market, aerospace, ~~decreased $12.0~~increased $5.0 million, or ~~32.3%, and sales to each of our other end markets also decreased. Compared to the third quarter of 2019, sales decreased by $19.1 million, or 33.8%~~29.1%. ~~This decrease was attributable to each of our end markets except for general industrial and heavy equipment, which~~Sales increased ~~$0.9 million, or 42.9%, and $0.3 million, or 7.1%, respectively.~~

~~The decrease~~ in ~~sales is a result of the current significant challenges facing~~ all our end markets ~~caused primarily by~~compared to the ~~COVID-19 pandemic. The most significant direct impact on our business has been~~fourth quarter of 2020, except for General Industrial.

Total company backlog, before surcharges, at the ~~slowdown in~~end of the ~~global commercial airline industry, which~~first quarter was $58.0 million, an increase of $10.0 million, or 21.0%, compared to the end of 2020. This is the ~~largest driver~~result of ~~the decline~~first quarter order entry that was stronger than any quarter in ~~sales for our aerospace end market.~~2020.

During the ~~third~~ quarter, ~~of 2020,~~ our sales of premium alloy products, which we define as all vacuum induction melt products, ~~represented $9.2~~totaled $7.6 million ~~or 24.5%~~and comprised 20.4% of total sales. ~~As a percent~~This percentage of sales ~~this~~ was an increase compared to both the ~~second quarter~~first and fourth quarters of ~~2020 and the third quarter of 2019.~~2020. Our premium alloy products are primarily sold to the aerospace end market.

~~Total company backlog, before surcharges, at~~Compared to the ~~end of the third~~first quarter of 2020, ~~was $54.8 million, a decrease of $64.3~~sales decreased by $21.5 million, or ~~54.0%, compared~~36.7%. The decrease was spread among all our end markets and is primarily due to the ~~end~~economic impact of ~~2019. The decrease in the backlog is due to a decline in new order entry caused by~~ the COVID-19 ~~pandemic.~~pandemic on our customers and the markets we serve.

Our gross margin for the ~~third~~first quarter was ~~negative $4.4~~a loss of $0.2 million, or negative ~~11.8%~~0.7% of net sales, compared to a loss of $5.1 million, or negative 16.2% of net sales, for the fourth quarter of 2020. Gross margin in the first quarter of 2020 was $4.9 million, or positive 8.4% of net sales. The first quarter 2021 negative ~~gross~~ margin ~~in the current quarter~~ was ~~primarily~~ due to direct charges ~~associated with~~recorded to the income statement as a result of lower activity ~~levels. Due to~~levels caused by the COVID-19 pandemic. As lower activity levels at our production facilities ~~caused by~~continued in the ~~COVID-19 pandemic, management revised its accounting estimates for the absorption~~first quarter of ~~costs into inventory. As a result, $4.3~~2021, $2.6 million of fixed overhead costs were not absorbed into inventory and ~~$2.1 million of negative operating efficiency variances~~ were ~~incurred. The total impact of $6.4 million was~~ charged directly to expense induring the quarter.

Selling, General and Administrative (“SG&A”) expenses were $4.2 million, or 11.1% of net sales, in the third quarter of 2020 compared to $5.4 million, or 10.3% of net sales, in the second quarter of 2020 and $4.5 million, or 8.0% of net sales, in the third quarter of 2019. Although increased as a percent of sales, SG&A expenses have decreased for the second consecutive quarter due primarily to strategic actions to reduce spending.

~~The Company’s net loss for the quarter~~ Without these direct charges, gross margin was $7.0 million, compared to a net loss of $3.3 million for the second quarter of 2020 and net income of $0.8 million for the third quarter of 2019. Net loss for the third quarter, as adjusted for the fixed cost absorption charge of $3.3 million (net of tax) and a gain on receipt of insurance proceeds of $0.2 million (net of tax), totaled $3.9 million.6.2%.

While the Company’s four plants continued to operate throughout the ~~third~~first quarter, COVID-19 related challenges ~~continued to~~arose which negatively ~~impact~~impacted the efficiency of our operations. These challenges are expected to continue inthrough the ~~fourth~~second quarter and ~~into 2021. The far-reaching impacts of the pandemic have impacted and will~~may continue to ~~impact~~do so thereafter. All of these factors may have far reaching impacts on the Company’s backlog, end markets, overall operations, cash flows and financial results.

The scope and nature of these impacts, most of which are beyond the Company’s control, continue to evolve, and the outcome is uncertain. The ultimate extent of the effects of the COVID-19 pandemic on the Company, and the end markets we serve, is highly uncertain and will depend on future ~~developments. As~~developments and as such ~~the~~ effects could exist for an extended period, even after the pandemic may end.

Three months ended ~~September 30, 2020~~March 31, 2021 as compared to the three months ended ~~September 30, 2019:~~March 31, 2020:

	Three months ended September 30,												Three months ended March 31,
(in thousands, except shipped ton information)	2020				2019								2021				2020

	Amount		Percentage of net sales		Amount		Percentage of net sales		Dollar / ton variance		Percentage variance		Amount		Percentage of net sales		Amount		Percentage of net sales		Dollar / ton variance		Percentage variance
						-
Net sales	$	37,434	100.0		$	56,568	100.0			(19,134)	(33.8)		$	37,038	100.0		$	58,494	100.0		$	(21,456)	(36.7)
Cost of products sold		41,861	111.8			51,260	90.6			(9,399)	(18.3)			37,286	100.7			53,585	91.6			(16,299)	(30.4)
						-
Gross margin		(4,427)	(11.8)			5,308	9.4			(9,735)	(183.4)			(248)	(0.7)			4,909	8.4			(5,157)	(105.1)
Selling, general and administrative expenses		4,153	11.1			4,525	8.0			(372)	(8.2)			5,231	14.1			5,908	10.1			(677)	(11.5)
						-		��
Operating (loss) income		(8,580)	(22.9)			783	1.4			(9,363)	NM
Operating loss														(5,479)	(14.8)			(999)	(1.7)			(4,480)	(448.4)
Interest expense		586	1.6			989	1.7			(403)	(40.7)			494	1.3			896	1.5			(402)	(44.9)
Deferred financing amortization		56	0.1			56	0.1			-	-			56	0.2			56	0.1			-	-
Other expense, net		(288)	(0.8)			(452)	(0.8)			(164)	36.3
Other expense (income), net														16	-			(17)	-			33	194.1
						-
(Loss) income before income taxes		(8,934)	(23.8)			190	0.4			(9,124)	NM
(Benefit) provision for income taxes		(1,934)	(5.2)			(577)	(1.0)			(1,357)	235.2
Loss before income taxes														(6,045)	(16.3)			(1,934)	(3.3)			(4,111)	(212.6)
Income taxes														(1,516)	(4.1)			(523)	(0.9)			(993)	(189.9)
						-
Net (loss) income	$	(7,000)	(18.6)	%	$	767	1.4	%	$	(7,767)	NM
Net loss													$	(4,529)	(12.2)	%	$	(1,411)	(2.4)	%	$	(3,118)	(221.0)
						-
Tons shipped		6,046				9,776				(3,730)	(38.2)			7,048				10,120				(3,072)	(30.4)
						-
Sales dollars per shipped ton	$	6,192			$	5,786			$	406	7.0	%	$	5,255			$	5,780			$	(525)	(9.1)	%

Melt Type Information
	Three months ended September 30,												Three months ended March 31,
(in thousands)	2020				2019								2021				2020
	Amount		Percentage of net sales			Amount	Percentage of net sales		Dollar variance		Percentage variance		Amount		Percentage of net sales			Amount	Percentage of net sales		Dollar variance		Percentage variance
Net sales:
Specialty alloys	$	27,847	74.4	%	$	47,730	84.4	%	$	(19,883)	(41.7)	%	$	29,091	78.5	%	$	49,920	85.3	%	$	(20,829)	(41.7)	%
Premium alloys (A)		9,165	24.5			8,043	14.2			1,122	14.0			7,553	20.4			7,664	13.1			(111)	(1.4)
Conversion services and other sales		422	1.1			795	1.4			(373)	(46.9)
Conversion services and other														394	1.1			910	1.6			(516)	(56.7)

Total net sales	$	37,434	100.0	%	$	56,568	100.0	%	$	(19,134)	(33.8)	%	$	37,038	100.0	%	$	58,494	100.0	%	$	(21,456)	(36.7)	%

The majority of our products are sold to service centers rather than the ultimate end market customers. The end market information in this Quarterly Report is our estimate based upon our knowledge of our customers and the grade of material sold to them, which they will in-turn sell to the ultimate end market customer.

End Market Information
	Three months ended September 30,													Three months ended March 31,
(in thousands)	2020				2019									2021				2020
	Amount		Percentage of net sales		Amount		Percentage of net sales		Dollar variance		Percentage variance			Amount		Percentage of net sales		Amount		Percentage of net sales		Dollar variance		Percentage variance
Net sales:
Aerospace	$	25,138	67.2	%	$	40,876	72.3	%	$	(15,738)	(38.5)	%		$	22,227	60.0	%	$	42,398	72.5	%	$	(20,171)	(47.6)	%
Power generation		1,590	4.2			2,884	5.1			(1,294)	(44.9)				1,199	3.2			2,217	3.8			(1,018)	(45.9)
Oil & gas		2,755	7.4			5,653	10.0			(2,898)	(51.3)				3,066	8.3			4,404	7.5			(1,338)	(30.4)
Heavy equipment		4,662	12.5			4,352	7.7			310	7.1				8,080	21.8			6,141	10.5			1,939	31.6
General industrial, conversion services and other sales		3,289	8.7			2,803	4.9			486	17.3
General industrial, conversion services and other													General industrial, conversion services and other		2,466	6.7			3,334	5.7			(868)	(26.0)

Total net sales	$	37,434	100.0	%	$	56,568	100.0	%	$	(19,134)	(33.8)	%		$	37,038	100.0	%	$	58,494	100.0	%	$	(21,456)	(36.7)	%

Net sales for the three months ended ~~September 30, 2020~~March 31, 2021 decreased ~~$19.1~~$21.5 million, or ~~33.8%~~36.7%, compared to the same ~~quarter~~period in the prior year. This is driven by a decrease in tons shipped, primarily in our aerospace and oil and gas end markets. The decrease in aerospace is a result of the current significant challenges facing the commercial airline industry caused primarily by the COVID-19 pandemic. The decrease in oil and gas is primarily a result of a general decline in demand in the sectorwas caused by the economic impact of the COVID-19 ~~pandemic.~~pandemic on our customers and end markets, and ultimately our order levels.

As a percent of sales, our gross margin for the three months ended ~~September 30, 2020~~March 31, 2021 was negative ~~11.8%~~0.7% compared to positive ~~9.4%~~8.4% for the three months ended ~~September 30, 2019.~~March 31, 2020. The decrease is ~~primarily the result of~~due to direct charges ~~associated with~~recorded to the income statement as a result of lower activity levels ~~and actions taken~~caused by the COVID-19 pandemic. As lower activity levels at our production facilities continued in ~~response to~~ the ~~economic downturn in our largest end markets. The direct charges totaled $6.4 million and included $4.3~~first quarter of 2021, $2.6 million of ~~excess~~ fixed overhead costs ~~that~~ were not absorbed into inventory and ~~$2.1~~$1.8 million of negative operating efficiency variances were incurred. The total impact of $4.4 million was charged directly to expense during the quarter. Without these direct charges, gross margin was 11.1%.

Our selling, general and administrative (“SG&A&A”) expenses consist primarily of employee costs, which include salaries, payroll taxes and benefit related costs, professional services, stock compensation and insurance costs. SG&A expenses decreased by ~~$0.4~~$0.7 million for the three months ended ~~September 30, 2020~~March 31, 2021 compared to the same period in the prior year. The decrease was ~~driven by strategic actions~~primarily due to ~~reduce spending~~lower net salary and ~~a decrease in employee-related~~benefit related costs, ~~partially offset by an increase in the cost of business insurance.~~due to lower headcount.

Interest expense totaled approximately ~~$0.6~~$0.5 million ~~for the three months ended September 30, 2020, compared with $1.0 million for the same period~~ in the ~~prior year. Interest expense was lower due~~first quarter of 2021 compared to $0.9 million in the first quarter of 2020. The decrease reflects the benefit of lower interest rates ~~on our~~as well as lower overall average debt ~~and lower average outstanding debt~~ levels.

Our estimated annual effective tax rate applied to ordinary income at September 30, 2020 was 23.7%. The difference between the statutory rate and the projected annual ETR is primarily due to research and development credits. Our ETR for the quarter was 21.6%, which is lower than the projected annual ETR primarily due to discrete expense for the expiration of stock options.

Our estimated annual effective tax rate applied to ordinary income at September 30, 2019 was 11.2%. Including the effect of discrete items, we recorded an income tax benefit for the three months ended September 30, 2019, primarily due to increased research and development tax credits.

For the three months ended ~~September 30,~~March 31, 2021 and 2020, ~~the Company recorded a net loss of $7.0 million, or $0.79 per diluted share, compared to net income of $0.8 million, or $0.09 per diluted share, for the three months ended September 30, 2019.~~

~~Nine months ended September 30, 2020 compared to the nine months ended September 30, 2019:~~

Nine months ended September 30,

(in thousands, except shipped ton information)

2020

2019

Amount

Percentage of net sales

Amount

Percentage of net sales

Dollar / ton variance

Percentage variance

Total net sales

$

148,407

100.0

$

187,836

100.0

(39,429
)

(21.0
)

Cost of products sold

145,988

98.4

166,052

88.4

(20,064
)

(12.1
)

Gross margin

2,419

1.6

21,784

11.6

(19,365
)

(88.9
)

Selling, general and administrative expenses

15,458

10.4

15,095

8.0

363

2.4

Operating (loss) income

(13,039
)

(8.8
)

6,689

3.6

(19,728
)

(294.9
)

Interest expense

2,232

1.5

2,809

1.5

(577
)

(20.5
)

Deferred financing amortization

169

0.1

171

0.1

(2
)

(1.2
)

Other income, net

(302
)

(0.2
)

(421
)

(0.2
)

119

(28.3
)

(Loss) income before income taxes

(15,138
)

(10.2
)

4,130

2.2

(19,268
)

(466.5
)

(Benefit) provision for income taxes

(3,396
)

(2.3
)

55

-

(3,451
)

NM

Net (loss) income

$

(11,742
)

(7.9
)
%

$

4,075

2.2

%

$

(15,817
)

388.1

Tons shipped

25,153

31,656

(6,503
)

(20.5
)

Sales dollars per shipped ton

$

5,900

$

5,934

$

(34
)

(0.6
)
%

Market Segment Information

Nine months ended September 30,

(in thousands)

2020

2019

Amount

Percentage of net sales

Amount

Percentage of net sales

Dollar
variance

Percentage variance
Net sales:

Service centers

$

103,877

70.0

%

$

129,996

69.2

%

$

(26,119
)

(20.1
)
%
Original equipment manufacturers

16,624

11.2

19,318

10.3

(2,694
)

(13.9
)

Rerollers

13,612

9.2

20,016

10.7

(6,404
)

(32.0
)

Forgers

12,027

8.1

15,408

8.2

(3,381
)

(21.9
)

Conversion services and other sales

2,267

1.5

3,098

1.6

(831
)

(26.8
)

Total net sales

$

148,407

100.0

%

$

187,836

100.0

%

$

(39,429
)

(21.0
)
%

End Market Information

Nine months ended September 30,

(in thousands)

2020

2019

Amount

Percentage of net sales

Amount

Percentage of net sales

Dollar
variance

Percentage variance
Net sales:

Aerospace

$

104,686

70.5

%

$

132,818

70.7

%

$

(28,132
)

(21.2
)
%
Power generation

5,923

4.0

8,588

4.5

(2,665
)

(31.0
)

Oil & gas

10,778

7.3

18,767

10.0

(7,989
)

(42.6
)

Heavy equipment

16,364

11.0

17,973

9.6

(1,609
)

(9.0
)

General industrial, conversion services and other sales

10,656

7.2

9,690

5.2

966

10.0

Total net sales

$

148,407

100.0

%

$

187,836

100.0

%

$

(39,429
)

(21.0
)
%

Net sales for the nine months ended September 30, 2020 decreased $39.4 million, or 21.0%, compared to the nine months ended September 30, 2019. This is primarily due to a decrease in consolidated shipment volume of 20.5%. The decrease in volume is driven by significant challenges facing the end markets in which we participate, most notably aerospace and oil & gas. Challenges in our aerospace end market are primarily related to the decline in the commercial airline industry caused by the COVID-19 pandemic. The decrease in oil and gas is primarily a result of a cyclical decline in demand for our products in line with a decline in worldwide oil prices, which has also been exacerbated by the COVID-19 pandemic.

Our gross margin, as a percent of sales, was 1.6% for the nine months ended September 30, 2020 compared to 11.6% for the nine months ended September 30, 2019. The decrease is primarily the result of direct charges associated with lower activity levels, actions taken in response to the economic downturn in our largest end markets, and product mix.

Our SG&A expenses consist primarily of employee costs, which include salaries, payroll taxes and benefit related costs, professional services, stock compensation and insurance costs. SG&A expenses increased by $0.4 million for the nine months ended September 30, 2020 compared to the same period in the prior year. The increase is primarily due to higher business insurance costs and employee severance costs, partially offset by lower employee incentive compensation accruals.

Interest expense for the nine months ended September 30, 2020 was $0.6 million lower than the same period in the prior year due to lower interest rates on our debt and lower average outstanding debt levels.

~~For the nine months ended September 30, 2020 and 2019,~~ our estimated annual effective tax rates applied to ordinary income were ~~23.7%~~25.8% and ~~11.2%~~28.3%, respectively. The difference between the federal statutory rate of 21.0% and the projected annual ETR of ~~23.7%~~25.8% for ~~2020~~2021 is primarily due to research and development credits.

Discrete items during the ~~nine~~three months ended ~~September 30, 2019 reduced tax expense by $0.4 million, primarily due to increased research~~March 31, 2021 and ~~development tax credits. Including the effect of discrete items,~~2020 were not significant, and our ETR for the ~~nine months ending September 30, 2019~~first quarter in each year was ~~1.3%~~25.1% and 27.0%, respectively.

For the ~~nine~~three months ended ~~September 30, 2020,~~March 31, 2021, the Company recorded a net loss of ~~$11.7~~$4.5 million, or ~~$1.33~~$0.51 per diluted share, compared to a net ~~income~~loss of ~~$4.1~~$1.4 million, or ~~$0.46~~$0.16 per diluted share, for the ~~nine~~three months ended ~~September 30, 2019.~~

Historically, we have financed our operations through cash provided by operating activities and borrowings on our credit facilities. At ~~September 30, 2020,~~March 31, 2021, we maintained approximately ~~$44.1~~$38.8 million of remaining availability under our revolving credit facility.

We ~~currently~~ believe that our cash flows from continuing operations, ~~and~~as well as available ~~borrowing capacity~~borrowings under our credit facility are adequate to satisfy our working capital, capital expenditure requirements, and other contractual obligations for the foreseeable future, including at least the next 12 months. ~~This belief~~

On April 16, 2020, the Company entered into a promissory note, dated April 15, 2020, with PNC Bank, National Association, evidencing an unsecured loan with a principal amount of $10.0 million made to the Company pursuant to the Paycheck Protection Program (the “PPP Term Note”) under the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The PPP Term Note is ~~based~~guaranteed by the United States Small Business Administration.

The PPP Term Note bears interest at a fixed annual rate of 1.00%, with the first six months of interest deferred. According to the terms of the PPP Term Note, the Company would begin to make 18 equal monthly payments of principal and interest in ~~part~~November 2020 with the final payment due in April 2022. The PPP Term Note may be accelerated upon the occurrence of an event of default. The Company applied for forgiveness of the PPP Term Note during the third quarter of 2020.

As of March 31, 2021, the Company has not made any principal or interest payments related to the PPP Term Note.

The Company anticipates forgiveness of the entire amount of the PPP Term Note; however, we are unable to estimate the timing of the completion of the forgiveness process. We have elected to classify the full principal balance of the PPP Term Note within Long-term debt, net on the ~~continued benefits~~consolidated balance sheet as of ~~strategic cost savings and spend reduction actions implemented by~~March 31, 2021. Under the ~~Company.~~existing terms of the PPP Term Note, if no forgiveness were granted the entire principal amount would be due within approximately twelve months.

During the ~~nine~~three months ended ~~September 30, 2020,~~March 31, 2021, net cash ~~provided by~~of $1.6 million was generated from operating ~~activities was $12.6 million.~~activities. Our net loss, after adjustments for non-cash expenses, ~~generated $0.7~~used $0.9 million. We generated ~~$8.6~~$1.1 million of cash from managed working capital, which we define as net accounts receivable, plus inventory, ~~and~~ minus accounts ~~payable.~~payable, minus other current liabilities. Accounts receivable ~~decreased~~increased $2.6 million due to ~~lower~~higher sales, while inventory increased $0.6 million. Accounts payable increased $6.1 million due to increased production activity compared to the end of 2020, and ~~both~~other current liabilities decreased $1.9 million. We also generated $1.5 million of cash from other assets and liabilities.

During the three months ended March 31, 2020, net cash used in operating activities was $7.8 million. Our net loss, after adjustments for non-cash expenses, generated $3.6 million. We utilized $10.2 million of cash from managed working capital. Accounts receivable increased $1.0 million, due to higher sales, while inventory ~~and accounts~~was approximately flat. Accounts payable decreased $9.2 million due to ~~lower~~decreased melt activity ~~levels~~ and ~~lower purchasing related to strategic~~timing of payments in the quarter, and a reduction in operational spend ~~reduction initiatives.~~activity. The balance of other current liabilities was approximately flat. In addition, we ~~generated $3.3~~utilized $1.2 million of cash from other assets and liabilities, primarily ~~due to cash received from insurance claims.~~

During the nine months ended September 30, 2019, net cash used in operating activities was $9.1 million. Our net income, adjusted for non-cash expenses, generated $20.0 million. We utilized $21.2 millionconsisting of ~~cash for managed working capital. Accounts receivable increased $3.8 million due to the timing~~payments of sales and collections, and accounts payable decreased $9.7 million due to the timing of purchasing activity. We used $7.6 million in the growth of inventory to support our order backlog. In addition, we utilized $7.9 million of cash from other assets and liabilities, primarily decreased down payments from customers and decreased accruals for employee relatedaccrued employment costs.

During the ~~nine~~three months ended ~~September 30, 2020,~~March 31, 2021, we used ~~$8.5~~$2.7 million of cash for capital expenditures, compared to ~~$13.3~~$4.0 million for the same period in the prior year. ~~2020~~Approximately $1.7 million of the current quarter total is related to strategic projects to expand our melt and remelt capabilities related to premium products. 2021 capital spending is expected to approximate ~~$9.0 million to $10.0~~$11.0 million.

Net cash used in financing activities was $4.2 million for the nine months ended September 30, 2020. This includes the proceeds from our $10.0 million PPP Term Note (as defined below) received during the second quarter.

~~Net cash~~ provided by financing activities was ~~$19.5~~$1.3 million the three months ended March 31, 2021, compared to $11.9 million for the ~~nine months ended September 30, 2019~~same period in the prior year. The decrease was due to lower capital expenditures and ~~was driven by~~working capital needs.

Financing activities included the impacts of amending our credit agreement, primarily the proceeds of $8.6 million received from increasing our term loan principal balance to $15.0 million. The proceeds from the term loan facility and borrowings ~~under~~on our revolving credit facility were used to ~~fund capital expenditures and managed working capital needs.~~pay the $15.0 million in notes that matured during the quarter.

The cost of raw materials represents approximately ~~45 and~~ 40% of the cost of products sold in the first ~~nine~~three months of ~~2020~~2021 and ~~2019, respectively.~~2020. The major raw materials used in our operations include nickel, molybdenum, vanadium, chrome, iron and carbon scrap. Additionally, our Bridgeville facility uses graphite electrodes as a consumable supply in the melting process. We maintain sales price surcharge ~~mechanisms~~ to mitigate the risk of substantial raw material cost fluctuations. The market values for these raw materials and others continue to fluctuate based on supply and demand, market disruptions and

other factors. Over time, our surcharge ~~mechanisms~~ will effectively offset changes in raw material costs; however, during a period of rising or falling prices the timing will cause variation between reporting periods.

On ~~August 3, 2018,~~March 17, 2021, we entered into the ~~First~~Second Amended and Restated Revolving Credit, Term Loan and Security Agreement ~~(“Credit~~(the “Credit Agreement”), with PNC Bank, National Association, as administrative agent and co-collateral agent (the “Agent”), Bank of America, N.A., as co-collateral agent (“Bank of America”), the Lenders (as defined in the New Credit Agreement) party thereto from time to time and PNC Capital Markets LLC, as sole lead arranger and sole ~~bookrunner.~~bookrunner (“PNC Capital Markets”). The Credit Agreement replaces our prior credit agreement, and provides for a senior secured revolving credit facility in an aggregate principal amount not to exceed ~~$110.0~~$105.0 million (“Revolving Credit Facility”) and a senior secured term loan facility (“Term Loan”) in the amount of ~~$10.0~~$15.0 million (together with the Revolving Credit Facility, the “Facilities”).

The Company was in compliance with all the applicable financial covenants on the date we entered into the Credit Agreement and at ~~all reporting periods through September 30, 2020.~~ March 31, 2021.

Availability under the Credit Agreement is based on eligible accounts receivable and inventory. ~~Further, the~~The Company must maintain undrawn availability under the Credit Agreement of at least ~~an amount equal~~$11.0 million. That requirement can be overcome if the Company maintains a fixed charge coverage ratio of not less than 1.10 to ~~payments due~~1.0 measured on ~~the notes issued~~a rolling two quarter basis and calculated in ~~connection~~accordance with the ~~acquisition~~terms of the

~~North Jackson facility, as defined in the~~ Credit Agreement, plus 12.5% of the maximum borrowing amount of $110.0 million “(Minimum Liquidity”). At September 30, 2020, there were no payments due on the notes relevant to the Minimum Liquidity calculation. This requirement exists until the notes are paid in full, refinanced or extended.Agreement.

The Company is required to pay a commitment fee of 0.25% based on the daily unused portion of the Revolving Credit Facility.

On April 16, 2020, the Company entered into a promissory note, dated April 15, 2020, with PNC Bank, National Association (“PNC”), evidencing an unsecured loan with a principal amount of $10.0 million made to the Company pursuant to the Paycheck Protection Program (“PPP Term Note”) under the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The PPP Term Note is guaranteed by the United States Small Business Administration.

The Company applied for forgiveness of the PPP Term Note during the third quarter of 2020. The Company anticipates forgiveness of the entire amount of the PPP Term Note; however, we are unable to estimate the timing of the completion of the forgiveness process. We have elected to classify the entire principal balance of the PPP Term Note within Long-term debt, net on the consolidated balance sheet as of September 30, 2020. Under the existing terms of the PPP Term Note, if no forgiveness were granted approximately $6.7 million of the principal amount would be due within twelve months.

~~There are no further extension options remaining, and~~Company paid the remaining ~~aggregate~~ principal balance ofand all applicable interest to settle the notes obligation.

The Notes ~~outstanding of $15.0 million has been classified within Current portion of long-term debt as of September 30, 2020.~~

The Company periodically enters into leases in its normal course of business. Operating lease liabilities and right-of-use assets are recorded to the consolidated balance sheet at the present value of minimum lease payments. The assets are included in Other long-term assets in the consolidated balance sheets and are amortized over the respective terms, which are five years or less. The long-term component of the lease liability is recorded in Other long-term liabilities, net and the current component is included in Other current liabilities.

The right-of-use assets and lease liabilities for finance leases are recorded at the present value of minimum lease payments. The assets are included in Property, plant and equipment, net on the consolidated balance sheets and are depreciated over the respective lease terms. The long-term component of the lease liability is included in Long-term debt and the current component is included in Current portion of long-term debt.

The Company entered into one new lease agreement accounted for as an operating during the first quarter of 2021, and did not enter into any finance lease agreements during the quarter.

The Company has reviewed its market risk and believes there are no significant changes from that disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2019,~~2020, except as provided in this Form 10-Q in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and in Part II. Item 1A. “Risk Factors.”

The Company’s management, including the Company’s Chairman, President and Chief Executive Officer (in his capacity as the Company’s principal executive, financial and ~~its Vice President of Finance, Chief Financial Officer and Treasurer,~~accounting officer), performed an evaluation of the effectiveness of the Company’s disclosure controls and procedures. Based on that evaluation, the Company’s Chairman, President and Chief Executive Officer ~~and its Vice President of Finance, Chief Financial Officer and Treasurer~~ concluded that, as of the end of the fiscal period covered by this quarterly report, the Company’s disclosure controls and procedures are effective. During the fiscal quarter ended ~~September 30, 2020,~~March 31, 2021, there were no changes in the Company’s internal control over financial reporting which have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

There are no material changes from the legal proceedings disclosed in Item 3. of the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2019.~~2020.

In addition to the other information set forth in this Quarterly Report on Form 10-Q, the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, ~~2019~~2020 could materially affect our business, financial conditions or future results. Those risk factors are not the only risks facing us. Additional risks and uncertainties not currently known or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or operating results. We believe that there have been no material changes in our risk factors from those disclosed in our Annual Report on Form 10-K for the year ended December 31, ~~2019, except for the additional factor described below.~~

~~Our business and operations, and the operations of our customers and suppliers, have been and are expected to continue to be adversely impacted by the COVID-19 pandemic.~~

The recent outbreak of COVID-19 has been declared by the World Health Organization to be a “pandemic” and has spread across the world, including the United States and many countries where the Company sells its products or sources raw materials.

Our operations and financial performance have been negatively impacted by the COVID-19 pandemic that has caused, and is expected to continue to cause, a global slowdown of economic activity, disruptions in global supply chains and significant volatility and disruption of financial markets. Because the severity, magnitude and duration of the COVID-19 pandemic and its economic consequences are uncertain, rapidly changing and difficult to predict, the COVID-19 pandemic’s impact on our operations and financial performance cannot be determined at this time. Further, the ultimate impact of the COVID-19 pandemic on our operations and financial performance depends on many factors that are not within our control, including, but not limited to, governmental, business and individuals’ actions that have been and continue to be taken in response to the pandemic (including restrictions on travel and transport and workforce pressures); the impact of the pandemic and actions taken in response on global and regional economies, travel and economic activity; general economic uncertainty in key global markets and financial market volatility; global economic conditions and levels of economic growth; commodity prices; and the pace of recovery when the COVID-19 pandemic subsides.

Notwithstanding our continued operations, we have experienced, and expect to continue experiencing, lower demand and volume for our products, including delivery and shipping delays and deferrals directly and indirectly to the COVID-19 pandemic that have adversely impacted, and are expected to continue to adversely impact, our businesses. For example, a significant portion of the sales result from products sold to customers in the commercial aerospace industry. In recent months, several commercial aerospace companies have announced cost-cutting and other measures in response to declining demand stemming from the COVID-19 pandemic, including measures to reduce inventory and/or downward adjustments to their production rates. Likewise, the COVID-19 pandemic has exacerbated declines in consumer activity and supply issues in the oil & gas end market. We expect that the longer the period of economic and global supply chain and disruption continues, the more material the adverse impact will be on our business operations, financial performance and results of operations.

As the impact of the COVID-19 pandemic on the economy and our operations evolves, we will continue to assess our liquidity position in relation to our anticipated future liquidity needs. Under the terms of our Credit Agreement, our borrowing availability is based on eligible accounts receivable and inventory, which have been reduced to lower levels as a result of the challenging economic environment we have faced during the COVID-19 pandemic, and which may continue to be reduced as the COVID-19 pandemic persists. Also, a continued worldwide disruption could materially affect our future access to our sources of liquidity, financial condition, capitalization and capital investments. In the event of a sustained market deterioration, we may need additional liquidity, which would require us to evaluate available alternatives and take appropriate actions. Additionally, a prolonged period of generating lower cash from operations could adversely affect our financial condition and the achievement of our strategic objectives. Conditions in the financial and credit markets also may limit the availability of funding or increase the cost of funding, which could adversely affect our business, financial position and results of operations.2020.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	DESCRIPTION	PAGE NO.

PART I.	FINANCIAL INFORMATION	1

Item 1.	Financial Statements	1

	Consolidated Statements of Operations	1

	Consolidated Statements of Comprehensive ~~(Loss) Income~~Loss	2

	Consolidated Balance Sheets	3

	Consolidated Statements of Cash Flow	4

	Consolidated Statements of Shareholders' Equity	5

	Notes to the Unaudited Consolidated Financial Statements	6

Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	13

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	2018

Item 4.	Controls and Procedures	2018

PART II.	OTHER INFORMATION	2119

Item 1.	Legal Proceedings	2119

Item 1A.	Risk Factors	2119

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	2119

Item 3.	Defaults Upon Senior Securities	2119

Item 4.	Mine Safety Disclosures	2119

Item 5.	Other Information	2119

Item 6.	Exhibits	2220

SIGNATURES		2321

Exhibit Number		Exhibit

31.1		Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).

31.2		Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).

32.1		Certification of Chief Executive Officer and Chief Financial Officer pursuant to Rule 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).

101		The following financial information from this Quarterly Report on Form 10-Q for the fiscal quarter ended ~~June 30, 2020,~~March 31, 2021, formatted in ~~inline~~ XBRL (Extensible Business Reporting Language) and filed electronically herewith: (i) the Consolidated Balance Sheets; (ii) the Consolidated Statements of Operations; (iii) the Consolidated Statements of Comprehensive ~~Income;~~Loss; (iv) the Consolidated Statements of Cash Flows; the Consolidated Statements of Shareholders’ Equity; and (v) the Notes to the Consolidated Financial Statements (filed herewith).

104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in the Exhibit 101 attachments)
		.

Date: ~~October~~April 21, ~~2020~~2021

/s/ Dennis M. Oates		~~/s/ Christopher T. Scanlon~~
Dennis M. Oates		~~Christopher T. Scanlon~~
Chairman, President and Chief Executive Officer		~~Vice President of Finance,~~
(Principal Executive, Financial and Accounting Officer)		~~Chief Financial Officer and Treasurer~~
		~~(Principal Financial and Accounting Officer)~~

Large accelerated filer	☐	Accelerated filer	☑

Non-accelerated filer	☐	Smaller reporting company	☑

Emerging growth company	☐

For the nine months ended September 30, 2019

Balance at December 31, 2018	8,752,490	$	9	$	93,100		$	146,191	$	1		292,855	$	(2,290	)
Common stock issuance under
Employee Stock Purchase Plan	9,270		-		128			-		-		-		-
Exercise of stock options	4,050		-		41			-		-		-		-
Share-based compensation	6,401		-		432			-		-		-		-
Net loss on derivative instruments	-		-		-			-		(67	)	-		-
Adoption of ASU 2018-02	-		-		-			21		(21	)	-		-
Net income	-		-		-			1,222		-		-		-
Balance at March 31, 2019	8,772,211	$	9	$	93,701		$	147,434	$	(87	)	292,855	$	(2,290	)
Common stock issuance under
Employee Stock Purchase Plan	11,182		-		152			-		-		-		-
Exercise of stock options	600		-		17			-		-		-		-
Share-based compensation	3,844		-		357			-		-		1,424		(21	)
Net gain on derivative instruments	-		-		-			-		154		-		-
Net income	-		-		-			2,086		-		-		-
Balance at June 30, 2019	8,787,837	$	9	$	94,227		$	149,520	$	67		294,279	$	(2,311	)
Common stock issuance under
Employee Stock Purchase Plan	-		-		(11	)		-		-		-		-
Share-based compensation	-		-		332			-		-		-		-
Net gain on derivative instruments	-		-		-			-		58		-		-
Net income	-		-		-			767		-		-		-
Balance at September 30, 2019	8,787,837	$	9	$	94,548		$	150,287	$	125		294,279	$	(2,311	)

Market Segment Information
	Three months ended March 31,
(in thousands)	2021				2020
	Amount		Percentage of net sales		Amount		Percentage of net sales		Dollar variance		Percentage variance
Net sales:
Service centers	$	25,844	69.8	%	$	42,884	73.3	%	$	(17,040)	(39.7)	%
Original equipment manufacturers		4,795	12.9			5,695	9.7			(900)	(15.8)
Rerollers		3,793	10.2			5,105	8.7			(1,312)	(25.7)
Forgers		2,212	6.0			3,900	6.7			(1,688)	(43.3)
Conversion services and other		394	1.1			910	1.6			(516)	(56.7)

Total net sales	$	37,038	100.0	%	$	58,494	100.0	%	$	(21,456)	(36.7)	%